UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000063319
Receipt number R000072473
Scientific Title Sex differences in the effects of caffeine ingestion on endurance performance
Date of disclosure of the study information 2026/10/16
Last modified on 2026/10/16 19:07:55

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Sex differences in the effects of caffeine ingestion on endurance performance

Acronym

Sex differences in the effects of caffeine ingestion on endurance performance

Scientific Title

Sex differences in the effects of caffeine ingestion on endurance performance

Scientific Title:Acronym

Sex differences in the effects of caffeine ingestion on endurance performance

Region

Japan


Condition

Condition

Healthy adults

Classification by specialty

Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

This study aimed to investigate sex differences in the effects of caffeine ingestion on endurance performance.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Time to exhaustion at 80% of peak oxygen uptake

Key secondary outcomes

Plasma adrenaline concentration, Serum estradiol concentration, Serum progesterone concentration, Fat oxidation


Base

Study type

Interventional


Study design

Basic design

Cross-over

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Prevention

Type of intervention

Food

Interventions/Control_1

Participants ingested caffeine capsules 60-min before exercise.

Interventions/Control_2

Participants ingested maltitol capsules 60-min before exercise.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit

30 years-old >

Gender

Male and Female

Key inclusion criteria

1.Participants who provided informed consent to participate in this study.
2.Participants who exercise regularly (at least 240 minutes/week, 2 or more times/week)
3.Participants who have a normal menstrual cycle of 25 to 38 days (Females only)

Key exclusion criteria

1.smoker.
2.obesity (body mass index >30kg/m2).
3.metabolic disease

Target sample size

24


Research contact person

Name of lead principal investigator

1st name Mikako
Middle name
Last name Sunaga

Organization

Nippon Sport Science University

Division name

Faculty of Childhood Sport Education

Zip code

158-8508

Address

7-1-1 Fukasawa, Setagaya-ku, Tokyo

TEL

03-5706-0966

Email

sunaga@nittai.ac.jp


Public contact

Name of contact person

1st name Megumi
Middle name
Last name Wanifuchi

Organization

Nippon Sport Science University

Division name

Graduate School

Zip code

158-8508

Address

7-1-1 Fukasawa, Setagaya-ku, Tokyo

TEL

03-5706-0966

Homepage URL


Email

25sda08@nittai.ac.jp


Sponsor or person

Institute

Nippon Sport Science University

Institute

Department

Personal name



Funding Source

Organization

Nippon Sport Science University

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Nippon Sport Science University

Address

7-1-1 Fukasawa, Setagaya-ku, Tokyo

Tel

03-5706-0931

Email

rinri-shinsa@nittai.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2026 Year 10 Month 16 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

24

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2025 Year 05 Month 01 Day

Date of IRB

2025 Year 06 Month 30 Day

Anticipated trial start date

2025 Year 07 Month 10 Day

Last follow-up date

2026 Year 03 Month 20 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2026 Year 10 Month 16 Day

Last modified on

2026 Year 10 Month 16 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000072473